Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeadache is a recognised side effect of Wegovy (semaglutide), listed in the medicine's prescribing information and reported by a meaningful share of participants across clinical trials. It tends to appear in the first few weeks of treatment or after a dose increase, and most people find it settles on its own within days. These are prescription-only medicines; a clinician assesses suitability and talks through the full side-effect picture before any treatment starts. The sections below walk through what drives the headaches, how to manage them day to day, and the symptoms that need prompt medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works partly by slowing how quickly the stomach empties and reducing appetite. Both effects can reduce how much fluid and food you take in, particularly in the days after a new injection or a dose increase. That drop in intake is the most common mechanical reason people develop a headache on Wegovy, rather than the medicine acting directly on headache pathways.
The NHS semaglutide medicines page confirms headache as a known side effect, placing it alongside the more frequently reported gastrointestinal symptoms such as nausea and constipation. In the STEP 1 clinical trial (68 weeks, 2.4 mg semaglutide versus placebo) headache was reported more often in the active treatment group, with the signal concentrated around dose escalation periods.
Practically, this means headaches are most likely in the two to four days after your weekly injection and in the weeks following each step up in dose. If yours follows that rhythm, it is a recognisable pattern rather than a sign something has gone wrong, and our page on whether a headache is a side effect of Wegovy explains in detail why this happens and how common it is. Keeping a brief note of when headaches arrive relative to injection day takes under a minute and gives your prescriber useful information at your next review.
You can read a broader breakdown of Wegovy's side-effect profile on our Wegovy side effects page.
Because fluid and calorie depletion drive most headaches in this context, the first responses are straightforward. Drink water consistently across the day rather than in large amounts at once, since gulping can worsen nausea and paradoxically reduce net fluid intake. Plain, low-fat snacks eaten slowly (crackers, plain rice, a banana) can help if hunger or blood-sugar dips are contributing.
Over-the-counter paracetamol is generally suitable for mild to moderate headache during Wegovy treatment. If you regularly reach for ibuprofen or aspirin instead, it is worth checking with a pharmacist first, since non-steroidal anti-inflammatory medicines have their own considerations for some people on weight-management programmes.
Caffeine withdrawal is a frequently overlooked trigger. Wegovy's appetite suppression often extends to hot drinks; if your morning coffee intake has dropped sharply since starting treatment, that reduction alone can produce significant headaches in the first week or two. Tapering gradually rather than stopping abruptly tends to help.
Rest and reducing screen time during an acute headache are simple and underused. Our Wegovy and headaches page covers the interaction between these lifestyle factors and semaglutide in more detail.
Most headaches during Wegovy treatment are mild and self-limiting. A small number are not, and this section is the one to read carefully.
Get medical help the same day (call 111 or attend urgent care) if your headache is:
People with type 2 diabetes using semaglutide should be aware that sudden vision changes can also signal diabetic retinopathy changes, this is documented in the prescribing information and warrants prompt assessment rather than watchful waiting.
If you are unsure whether your headache fits a concerning pattern, the NHS 111 service can advise. For any suspected side effect, including headache, you or your prescriber can make a report through the MHRA Yellow Card scheme, your report contributes to the ongoing safety monitoring of these medicines.
Further detail on what to expect in the days after an injection is covered on our page about what to do if you get a headache after taking Wegovy, and if you want a closer look at what happens specifically in the hours following your Wegovy shot, that page walks through the timing and typical features in detail.
If headache continues well beyond the first few weeks at a stable dose, it is worth discussing with the clinician managing your treatment rather than assuming it will pass. There are a few questions worth considering together: whether the timing still tracks injection day, whether any other new medicines or supplements have been introduced, and whether blood pressure has been checked recently, since elevated blood pressure can produce headache independently and some people's readings shift during significant weight change.
Headache that reappears each time a dose increases and then settles is usually tolerated without changing the titration plan. Headache that does not settle or that affects quality of life is a legitimate reason to discuss whether the current schedule is the right one for you, slower titration is sometimes appropriate.
The headache pattern can also cross over with semaglutide-related headache reported across the GLP-1 class more broadly; your prescriber can consider the whole picture. At nume, a real clinician reviews your consultation the same day and remains available for follow-up questions through our aftercare team. If you would like to discuss how Wegovy's side effects apply to your circumstances, you can start your free consultation with our prescribers and get a personal clinical assessment rather than a generic answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.